MALAT1 and Hodgkins lymphoma: Further, MALAT-1, a nuclear lncRNA, was reported to be targeted by miR-9 in an Ago-2-dependent manner in the nuclei of Hodgkin’s lymphoma and glioblastoma cell lines [15].